Originally available for subcutaneous injection ( e.g . over 2.5 hrs ) , in 2016 it gained EU approval in a formulation for intravenous injection for CLL .
Originally available for intravenous injection ( e.g . over 2.5 hrs ) , in 2016 it gained EU approval in a formulation for subcutaneous injection for CLL .